The quality of pharmaceutical care in community pharmacies is assessed by quality indicators (QIs), which are used to assess and improve the quality of medical practice. However, in order to operate QIs in clinical practice, the lack of methods that eliminate variations in operation records and can be measured without workload needs to be addressed. An organized database of electronic medication history (KAKEHASHI Inc.) was used in this study. The KAKEHASHI database consists of prescriptions and usage data for the support tools of medication guidance. In this study, we assessed the process of QI evaluation for diabetes medication guidance using the electronic medication history record to improve the medication guidance process. The rate of execution of medication guidance for hypoglycemia regarding sugar intake was 35±32% (Mean±SD) for sulfonylureas, 25±26% for biguanides, 28±28% for dipeptidyl peptidase-4 inhibitors, 26±27% for sodium-glucose cotransporter protein-2 inhibitors, 28±31% for alpha-glucosidase inhibitors, and 31±35% for thiazolidinediones. The rate of execution of guidance for adverse reactions was 12±19% for lactic acidosis induced by biguanides and 18±28% for heart failure induced by thiazolidinediones. To the best of our knowledge, this is the first study to evaluate QIs using electronic medication history records. These findings suggest that the approach used in the present study can be used to periodically evaluate medication guidance without increasing workload and can be utilized in the process of improving the quality of medication guidance by pharmacists.

Objective: The aim of this study was to examine the impact of the Japanese version of the PHOND study technique delivered across five communities by community pharmacists for patients with type 2 diabetes who are offered general diabetes treatment. The primary endpoints were changes in diabetes-related laboratory parameters, such as hemoglobin A1c (HbA1c) levels and rates of health activity achievement. Results: Sixty-four patients with type 2 diabetes were followed up for 6 months. HbA1c levels were lower at follow-up than at baseline in the group with baseline HbA1c 7.0%≤ (7.5%±0.5% vs. 7.3%±0.5%). Healthy activity engagement rates were higher at follow-up than at baseline (63.8±29.1 points vs. 78.3±15.9 points). The PHOND study technique, which involves a collaboration between pharmacists and registered dietitians, may help provide access to care and promote self-management among patients with type 2 diabetes.